43 related articles for article (PubMed ID: 31736084)
1. Association between tumor mutation profile and clinical outcomes among Hispanic Latina women with triple-negative breast cancer.
Philipovskiy A; Dwivedi AK; Gamez R; McCallum R; Mukherjee D; Nahleh Z; Aguilera RJ; Gaur S
PLoS One; 2020; 15(9):e0238262. PubMed ID: 32886682
[TBL] [Abstract][Full Text] [Related]
2. Identification of CSNK1D and KLK6 as two common upregulated genes present in BRCA1 mutated triple-negative breast cancer and ovarian epithelial carcinoma.
Lakis F; Ayoub R; Faour WH; Makki M; Yassine H; Fayyad-Kazan H; Abdel Sater F
Nucleosides Nucleotides Nucleic Acids; 2024 May; ():1-14. PubMed ID: 38781585
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal quantitative microRNA-155 imaging reports immune-mediated changes in a triple-negative breast cancer model.
Skourti E; Volpe A; Lang C; Johnson P; Panagaki F; Fruhwirth GO
Front Immunol; 2023; 14():1180233. PubMed ID: 37359535
[TBL] [Abstract][Full Text] [Related]
4. A Provocative Molecular Link between Mammographic Density and BRCA1-loss associated TNBC.
Xu J; Olusola G; Footman A; Hansen N; Cheriyan AM; Koganti K; Reddy V; Yezdani S; Eddy V; De'smond H; Bakinde N; Okoli J; Oprea G; Gundry K; Reddy ESP; Rao VN
Int J Hum Genet Genet Disord; 2019; 1(1):1-8. PubMed ID: 33860286
[TBL] [Abstract][Full Text] [Related]
5. Quantification of MicroRNA in a Single Living Cell via Ionic Current Rectification-Based Nanopore for Triple Negative Breast Cancer Diagnosis.
Zhang S; Song L; Zheng R; Zhang F; Wang Q; Mao X; Fan JX; Liu B; Zhao YD; Chen W
Anal Chem; 2024 May; 96(19):7411-7420. PubMed ID: 38652893
[TBL] [Abstract][Full Text] [Related]
6. Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies.
Medina MA; Oza G; Sharma A; Arriaga LG; Hernández Hernández JM; Rotello VM; Ramirez JT
Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32245065
[TBL] [Abstract][Full Text] [Related]
7. Variant analysis of the first Lebanese SARS-CoV-2 isolates.
Abou-Hamdan M; Hamze K; Abdel Sater A; Akl H; El-Zein N; Dandache I; Abdel-Sater F
Genomics; 2021 Jan; 113(1 Pt 2):892-895. PubMed ID: 33091548
[TBL] [Abstract][Full Text] [Related]
8. Role of androgen and microRNA in triple-negative breast cancer.
Al-Othman N; Ahram M; Alqaraleh M
Breast Dis; 2020; 39(1):15-27. PubMed ID: 31839601
[TBL] [Abstract][Full Text] [Related]
9. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in lncRNA
Yang H; Sun Q; Chong F; Jiang X; Wang Y; Xu K; Zou Y; Xu L; Song C
Aging (Albany NY); 2021 Nov; 13(21):24360-24378. PubMed ID: 34762068
[TBL] [Abstract][Full Text] [Related]
11. miR-146a and miR-638 in BRCA1-deficient triple negative breast cancer tumors, as potential biomarkers for improved overall survival.
Zavala V; Pérez-Moreno E; Tapia T; Camus M; Carvallo P
Cancer Biomark; 2016; 16(1):99-107. PubMed ID: 26835710
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA in breast cancer: The association with BRCA1/2.
Petrovic N; Davidovic R; Bajic V; Obradovic M; Isenovic RE
Cancer Biomark; 2017; 19(2):119-128. PubMed ID: 28128741
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in regulation of triple-negative breast cancer progression.
Piasecka D; Braun M; Kordek R; Sadej R; Romanska H
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1401-1411. PubMed ID: 29923083
[TBL] [Abstract][Full Text] [Related]
14. Triple negative breast cancer: microRNA expression profile and novel discriminators according to BRCA1 status.
Abdel-Sater F; Najar M; Fayyad-Kazan H
J Cell Physiol; 2020 Jun; 235(6):5204-5212. PubMed ID: 31736084
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.
Matamala N; Vargas MT; González-Cámpora R; Arias JI; Menéndez P; Andrés-León E; Yanowsky K; Llaneza-Folgueras A; Miñambres R; Martínez-Delgado B; Benítez J
Oncotarget; 2016 Apr; 7(15):20068-79. PubMed ID: 26933805
[TBL] [Abstract][Full Text] [Related]
16. BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer.
Erturk E; Cecener G; Tezcan G; Egeli U; Tunca B; Gokgoz S; Tolunay S; Tasdelen I
Gene; 2015 Feb; 556(2):163-9. PubMed ID: 25445393
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
